1. Home
  2. OSIS vs AMPH Comparison

OSIS vs AMPH Comparison

Compare OSIS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • AMPH
  • Stock Information
  • Founded
  • OSIS 1987
  • AMPH 1996
  • Country
  • OSIS United States
  • AMPH United States
  • Employees
  • OSIS N/A
  • AMPH N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • AMPH Health Care
  • Exchange
  • OSIS Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • OSIS 2.8B
  • AMPH 2.5B
  • IPO Year
  • OSIS 1997
  • AMPH 2014
  • Fundamental
  • Price
  • OSIS $183.68
  • AMPH $40.85
  • Analyst Decision
  • OSIS Strong Buy
  • AMPH Buy
  • Analyst Count
  • OSIS 5
  • AMPH 4
  • Target Price
  • OSIS $179.00
  • AMPH $60.33
  • AVG Volume (30 Days)
  • OSIS 245.5K
  • AMPH 458.4K
  • Earning Date
  • OSIS 01-23-2025
  • AMPH 11-06-2024
  • Dividend Yield
  • OSIS N/A
  • AMPH N/A
  • EPS Growth
  • OSIS 41.23
  • AMPH 17.38
  • EPS
  • OSIS 7.68
  • AMPH 3.01
  • Revenue
  • OSIS $1,603,555,000.00
  • AMPH $723,549,000.00
  • Revenue This Year
  • OSIS $11.52
  • AMPH $16.86
  • Revenue Next Year
  • OSIS $5.19
  • AMPH $10.07
  • P/E Ratio
  • OSIS $23.96
  • AMPH $13.58
  • Revenue Growth
  • OSIS 24.35
  • AMPH 20.33
  • 52 Week Low
  • OSIS $120.42
  • AMPH $36.56
  • 52 Week High
  • OSIS $189.13
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 70.26
  • AMPH 31.08
  • Support Level
  • OSIS $179.89
  • AMPH $43.34
  • Resistance Level
  • OSIS $189.13
  • AMPH $45.39
  • Average True Range (ATR)
  • OSIS 4.24
  • AMPH 1.31
  • MACD
  • OSIS -0.37
  • AMPH -0.23
  • Stochastic Oscillator
  • OSIS 70.44
  • AMPH 8.36

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: